Site icon pharmaceutical daily

Global Wound Closure Devices Pipeline Report 2022 – Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others – ResearchAndMarkets.com

BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Wound Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering.

This report provides comprehensive information about the Wound Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Wound closure devices are used to close wounds that occur due to injuries or surgical procedures.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Reasons to Buy

The report enables you to:

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Products under Development

3.1 Wound Closure Devices – Pipeline Products by Stage of Development

3.2 Wound Closure Devices – Pipeline Products by Segment

3.3 Wound Closure Devices – Pipeline Products by Territory

3.4 Wound Closure Devices – Pipeline Products by Regulatory Path

3.5 Wound Closure Devices – Pipeline Products by Estimated Approval Date

3.6 Wound Closure Devices – Ongoing Clinical Trials

4 Wound Closure Devices – Pipeline Products under Development by Companies

4.1 Wound Closure Devices Companies – Pipeline Products by Stage of Development

4.2 Wound Closure Devices – Pipeline Products by Stage of Development

5 Wound Closure Devices Companies and Product Overview

6 Wound Closure Devices – Recent Developments

7 Appendix

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/itkuom

Source: GlobalData

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version